Cancer-specific innate and adaptive immune rewiring drives resistance to PD-1 blockade in classic Hodgkin lymphoma

Nat Commun. 2024 Dec 30;15(1):10740. doi: 10.1038/s41467-024-54512-7.

Abstract

Hodgkin Reed-Sternberg (HRS) cells of classic Hodgkin lymphoma (cHL), like many solid tumors, elicit ineffective immune responses. However, patients with cHL are highly responsive to PD-1 blockade, which largely depends on HRS cell-specific retention of MHC class II and implicates CD4+ T cells and additional MHC class I-independent immune effectors. Here, we utilize single-cell RNA sequencing and spatial analysis to define shared circulating and microenvironmental features of the immune response to PD-1 blockade in cHL. Compared with non-responders, responding patients have more circulating CD4+ naïve and central memory T cells and B cells, as well as more diverse CD4+ T cell and B cell receptor repertoires. Importantly, a population of circulating and tumor-infiltrating IL1β+ monocytes/macrophages is detectable in patients with cHL but not healthy donors, and a proinflammatory, tumor-promoting signature of these circulating IL1β+ monocytes is associated with resistance to PD-1 blockade in cHL. Altogether, our findings reveal extensive immune rewiring and complementary roles of CD4+ T cells, B cells and IL1β+ monocytes in the response to PD-1 blockade and suggest that these features can be captured with a peripheral blood test.

MeSH terms

  • Adaptive Immunity* / drug effects
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes* / immunology
  • Drug Resistance, Neoplasm* / immunology
  • Female
  • Hodgkin Disease* / drug therapy
  • Hodgkin Disease* / immunology
  • Hodgkin Disease* / pathology
  • Humans
  • Immune Checkpoint Inhibitors* / pharmacology
  • Immune Checkpoint Inhibitors* / therapeutic use
  • Immunity, Innate* / drug effects
  • Interleukin-1beta* / metabolism
  • Macrophages / immunology
  • Macrophages / metabolism
  • Male
  • Monocytes / drug effects
  • Monocytes / immunology
  • Monocytes / metabolism
  • Programmed Cell Death 1 Receptor* / antagonists & inhibitors
  • Programmed Cell Death 1 Receptor* / metabolism
  • Reed-Sternberg Cells / immunology
  • Reed-Sternberg Cells / metabolism
  • Reed-Sternberg Cells / pathology
  • Tumor Microenvironment* / drug effects
  • Tumor Microenvironment* / immunology

Substances

  • Programmed Cell Death 1 Receptor
  • Immune Checkpoint Inhibitors
  • Interleukin-1beta
  • PDCD1 protein, human
  • IL1B protein, human